- Home
- STT vs BNTX Comparison
STT vs BNTX Comparison
Compare STT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STT
- BNTX
- Stock Information
- Founded
- STT 1792
- BNTX 2008
- Country
- STT United States
- BNTX Germany
- Employees
- STT N/A
- BNTX N/A
- Industry
- STT Major Banks
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STT Finance
- BNTX Health Care
- Exchange
- STT Nasdaq
- BNTX Nasdaq
- Market Cap
- STT 25.8B
- BNTX 26.4B
- IPO Year
- STT N/A
- BNTX 2019
- Fundamental
- Price
- STT $112.13
- BNTX $97.88
- Analyst Decision
- STT Buy
- BNTX Strong Buy
- Analyst Count
- STT 12
- BNTX 18
- Target Price
- STT $117.33
- BNTX $139.49
- AVG Volume (30 Days)
- STT 1.7M
- BNTX 1.2M
- Earning Date
- STT 10-14-2025
- BNTX 11-03-2025
- Dividend Yield
- STT 3.00%
- BNTX N/A
- EPS Growth
- STT 67.51
- BNTX N/A
- EPS
- STT 8.92
- BNTX N/A
- Revenue
- STT $13,323,000,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- STT $6.98
- BNTX N/A
- Revenue Next Year
- STT $3.62
- BNTX $13.50
- P/E Ratio
- STT $12.56
- BNTX N/A
- Revenue Growth
- STT 10.97
- BNTX 6.98
- 52 Week Low
- STT $72.81
- BNTX $81.20
- 52 Week High
- STT $116.37
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- STT 49.66
- BNTX 39.45
- Support Level
- STT $110.45
- BNTX $90.12
- Resistance Level
- STT $113.21
- BNTX $104.48
- Average True Range (ATR)
- STT 1.97
- BNTX 4.00
- MACD
- STT -0.39
- BNTX -0.57
- Stochastic Oscillator
- STT 28.38
- BNTX 31.33
About STT State Street Corporation
State Street is a leading provider of financial services, including investment servicing, investment management, and investment research and trading. With approximately $47 trillion in assets under custody and administration and $4.7 trillion assets under management as of Dec. 31, 2024, State Street operates globally in more than 100 geographic markets and employs about 53,000 worldwide.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.